Clinical Trials

Showing trials with last updates posted in 2024.

NCT04375527 | TERMINATED | PHASE2
3 participants

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-04
Start Date:
2020-12-03
Completion:
2024-11-22
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC V8
  • Clinical Stage IV Cutaneous Melanoma AJCC V8
  • Locally Advanced Cutaneous Melanoma
  • Metastatic Cutaneous Melanoma
  • Pathologic Stage III Cutaneous Melanoma AJCC V8
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC V8
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC V8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC V8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC V8
  • Pathologic Stage IV Cutaneous Melanoma AJCC V8
  • Unresectable Cutaneous Melanoma
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT03916809 | RECRUITING | NA
30 participants

EMST in Patients Undergoing CRT for HNCA

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-04
Start Date:
2017-07-12
Completion:
2025-08-01
Conditions
  • Head and Neck Neoplasms
  • Deglutition Disorders
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page